BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10626347)

  • 1. Modifying the properties of platinum (IV) complexes in order to increase biological effectiveness.
    Hambley TW; Battle AR; Deacon GB; Lawrenz ET; Fallon GD; Gatehouse BM; Webster LK; Rainone S
    J Inorg Biochem; 1999 Oct; 77(1-2):3-12. PubMed ID: 10626347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.
    Hoffmeister BR; Hejl M; Adib-Razavi MS; Jakupec MA; Galanski M; Keppler BK
    Chem Biodivers; 2015 Apr; 12(4):559-74. PubMed ID: 25879501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of equatorial and axial carboxylato ligands on the kinetic inertness of platinum(IV) complexes in the presence of ascorbate and cysteine and within DLD-1 cancer cells.
    Chen CK; Zhang JZ; Aitken JB; Hambley TW
    J Med Chem; 2013 Nov; 56(21):8757-64. PubMed ID: 24107138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization and antitumor activity of novel octahedral Pt(IV) complexes.
    Kwon YE; Whang KJ; Park YJ; Kim KH
    Bioorg Med Chem; 2003 Apr; 11(8):1669-76. PubMed ID: 12659753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of the effects of oxidation and ring closure on the cytotoxicities of the platinum complexes of N-(2-hydroxyethyl)ethane-1,2-diamine and ethane-1,2-diamine-N,N'-diacetic acid.
    Davies MS; Wong PN; Battle AR; Haddad G; McKeage MJ; Hambley TW
    J Inorg Biochem; 2002 Jul; 91(1):205-11. PubMed ID: 12121777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs.
    Varbanov HP; Valiahdi SM; Kowol CR; Jakupec MA; Galanski MS; Keppler BK
    Dalton Trans; 2012 Dec; 41(47):14404-14415. PubMed ID: 22886297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, antitumor activity, and chemical properties of silaplatin and related platinum (II) and platinum (IV) complexes derived from beta-silyl amines.
    Anderson WK; Kasliwal R; Houston DM; Wang YS; Narayanan VL; Haugwitz RD; Plowman J
    J Med Chem; 1995 Sep; 38(19):3789-97. PubMed ID: 7562909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumor activity of (diamine)platinum(II) complexes of benzylmalonate derivatives.
    Lee YA; Chung YK; Sohn YS
    J Inorg Biochem; 1997 Dec; 68(4):289-94. PubMed ID: 9397577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New antitumour active platinum compounds containing carboxylate ligands in trans geometry: synthesis, crystal structure and biological activity.
    van Zutphen S; Pantoja E; Soriano R; Soro C; Tooke DM; Spek AL; den Dulk H; Brouwer J; Reedijk J
    Dalton Trans; 2006 Feb; (8):1020-3. PubMed ID: 16474887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
    J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs.
    Varbanov HP; Göschl S; Heffeter P; Theiner S; Roller A; Jensen F; Jakupec MA; Berger W; Galanski MS; Keppler BK
    J Med Chem; 2014 Aug; 57(15):6751-64. PubMed ID: 25032896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
    Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
    J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization, and antitumor activity of amine platinum(II) and (IV) tellurate complexes.
    Khokhar AR; Xu Q; Siddik ZH
    J Inorg Biochem; 1994 Mar; 53(4):295-301. PubMed ID: 8169608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
    Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
    J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumour activity of platinum(II) and platinum(IV) complexes containing ethylenediamine-derived ligands having alcohol, carboxylic acid and acetate substituents. Crystal and molecular structure of [PtL4CL2].H20 where L4 is ethylenediamine-N,N'-diacetate.
    Jolley JN; Yanovsky AI; Kelland LR; Nolan KB
    J Inorg Biochem; 2001 Jan; 83(2-3):91-100. PubMed ID: 11237267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, in vitro cytotoxicity, and interaction with DNA of platinum(II) complexes with N-monocycloalkyl derivatives of 1R,2R-diaminocyclohexane as carrier ligands.
    Sun Y; Gou S; Liu F; Yin R; Fang L
    ChemMedChem; 2012 Apr; 7(4):642-9. PubMed ID: 22247027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions.
    Escolà A; Crespo M; López C; Quirante J; Jayaraman A; Polat IH; Badía J; Baldomà L; Cascante M
    Bioorg Med Chem; 2016 Nov; 24(22):5804-5815. PubMed ID: 27670096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic differences in electrochemical reduction of the structurally characterized anti-cancer platinum(IV) complexes [Pt{((p-HC6F4)NCH2)2}-(pyridine)2Cl2], [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)2], and [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)Cl].
    Guo SX; Mason DN; Turland SA; Lawrenz ET; Kelly LC; Fallon GD; Gatehouse BM; Bond AM; Deacon GB; Battle AR; Hambley TW; Rainone S; Webster LK; Cullinane C
    J Inorg Biochem; 2012 Oct; 115():226-39. PubMed ID: 22921430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of (hydroxymethyl)pyridine and pyridine-carboxylic acids, in trans-position to the isopropylamine and amine ligands, on the cytotoxicity of platinum complexes.
    Medina RM; Rodríguez J; Quiroga AG; Ramos-Lima FJ; Moneo V; Carnero A; Navarro-Ranninger C; Macazaga MJ
    Chem Biodivers; 2008 Oct; 5(10):2090-2100. PubMed ID: 18972499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.